Metraipolis › archive › dc_0887d1ee95e2

Nimotuzumab combined with gemcitabine and nab-paclitaxel as first-line therapy for advanced pancreatic cancer: a single-arm, single-center Phase II… — Europe PMC PMID:42292240

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42292240
DOI
10.3389/fmed.2026.1838482
License (as archived)
solo-consultazione
Archived
2026-11-01T03:48:06.074Z
SHA-256 of the archived text
1305e9592adbffacfb863d9a8c9907fd0fa7c12a5f5c1cbe0a6ab8d9eaafc31a
Stable URL of this page
https://metraipolis.com/documento/dc_0887d1ee95e2

How to cite

Nimotuzumab combined with gemcitabine and nab-paclitaxel as first-line therapy for advanced pancreatic cancer: a single-arm, single-center Phase II… — Europe PMC PMID:42292240 — Europe PMC (en), https://europepmc.org/article/MED/42292240 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0887d1ee95e2 (Metraipolis archive dc_0887d1ee95e2, sha256 1305e9592adbffacfb863d9a8c9907fd0fa7c12a5f5c1cbe0a6ab8d9eaafc31a)
BibTeX
@misc{dc0887d1ee95e2,
  title = {Nimotuzumab combined with gemcitabine and nab-paclitaxel as first-line therapy for advanced pancreatic cancer: a single-arm, single-center Phase II… — Europe PMC PMID:42292240},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42292240},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0887d1ee95e2; sha256 1305e9592adbffacfb863d9a8c9907fd0fa7c12a5f5c1cbe0a6ab8d9eaafc31a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292240. Agents can read the archived copy with the MCP tool read_document.